ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her state of practice after we conducted our analysis. The updated address appears on this page.

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,043Medicare Part D Prescriptions Filled, Including Refills
$599K Total Retail Price of All Prescriptions
315 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 529 514
METOPROLOL SUCCINATE 398 392
AMLODIPINE BESYLATE 342 329
SIMVASTATIN 300 300
OMEPRAZOLE 252 252
PANTOPRAZOLE SODIUM 234 234
METOPROLOL TARTRATE 228 222
POTASSIUM CHLORIDE 225 224
WARFARIN SODIUM 218 218
FUROSEMIDE 189 189
HYDROCHLOROTHIAZIDE 179 179
LISINOPRIL 166 166
TAMSULOSIN HCL 143 143
RAMIPRIL 142 140
ATENOLOL 142 142
CLOPIDOGREL 140 140
NEXIUM 130 129
DIOVAN 128 122
ISOSORBIDE MONONITRATE ER 127 127
ATORVASTATIN CALCIUM 127 127
ZETIA 123 121
CRESTOR 122 122
PRADAXA 118 118
KLOR-CON 10 104 104
FAMOTIDINE 103 91
FLUOXETINE HCL 96 92
VERAPAMIL ER 94 94
DONEPEZIL HCL 94 94
KLOR-CON M20 93 93
DILTIAZEM 24HR CD 92 92
EVISTA 91 91
PLAVIX 91 91
GLIMEPIRIDE 90 86
METFORMIN HCL ER 88 88
BISOPROLOL-HYDROCHLOROTHIAZIDE 83 82
METFORMIN HCL 79 76
TRAMADOL HCL 75 65
PREDNISONE 74 68
ESCITALOPRAM OXALATE 70 48
LANTUS 70 70
ENALAPRIL MALEATE 70 63
ALLOPURINOL 67 67
DILTIAZEM 24HR ER 66 66
LOSARTAN POTASSIUM 65 65
IRBESARTAN 62 52
MECLIZINE HCL 59 58
DIOVAN HCT 54 54
CYMBALTA 52 52
CARVEDILOL 52 52
LABETALOL HCL 51 51
CITALOPRAM HBR 51 51
LOVAZA 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.